3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
12
Biopsy
10
Specimen Handling
9
Whole-Body Irradiation
7
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Etoposide
6
fludarabine
5
duvelisib
5
Brentuximab Vedotin
5
ruxolitinib
4
fludarabine phosphate
4
Vincristine
4
Prednisone
4
Doxorubicin
4
Cytarabine
4
10-propargyl-10-deazaaminopterin
4
romidepsin
3
X-Rays
3
Mycophenolic Acid
3
Immunoglobulin G
3
Granulocyte Colony-Stimulating Factor
3
Gemcitabine
3
Disulfides
3
Carmustine
3
venetoclax
2
tazemetostat
2
sodium-iodide symporter
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
sargramostim
×
1 year
×
Clear all
No trials found.